Roswell Park Pharmacy Oncology Symposium

Saturday, September 19, 2026
7:30 a.m.-2:15 p.m.

Registration information

Photo of the Roswell Park campus through Kaminski Park

The purpose of this activity is to provide updates in oncology treatment practices and management of toxicities relevant to palliative care, targeted and cellular therapies. The program is led by pharmacists and also focuses on medication safety and social determinants of health

Target audience

Pharmacists who practice in the oncology setting.

Program information

5.0 contact hours (0.5 CEU), knowledge-based program (no partial credit available). 

Attendees must be present for 70% or more of the activity. Additionally, completion of the post-activity assessment (embedded in the activity evaluation) is a requirement for obtaining continuing education credit, however, there is no minimum passing score. It is strongly encouraged that all attendees participate in the active learning components of the program as well as the question and answer session.

Accreditation information Register today Contact us

Saturday, September 19, 2026
7:30 a.m.-2:15 p.m.

Gaylord Cary Conference Room
Research Studies Center - Roswell Park Comprehensive Cancer Center
665 Carlton St.
Buffalo, NY 14203

*Parking is available in the Roswell Park parking ramp at Elm and Carlton Streets.

Speakers

Jeffrey Baron, PharmD, BCOP
Clinical Pharmacist
Roswell Park Comprehensive Cancer Center
No picture available
Chris Jadoch, RPh 
Executive Director, Formulary & Supply Chain Management
Roswell Park Comprehensive Cancer Center
Alex Varkey headshot
Alex Varkey, PharmD, MS, FAPhA
Vice President, Client Success
Visante
Bryan Fitzgerald, University of Rochester headshot
Bryan Fitzgerald, PharmD, BCOP
Pharmacist
University of Rochester Medical Center
Joseph Elijah, Northeastern University School of Pharmacy headshot
Joseph Elijah, PharmD, BCOP, BCPS
Clinical Pharmacist Specialist - Thoracic Oncology
Henry Ford Hospital - Detroit

Learning objectives

  • Explain how human-centered leadership influences engagement and organizational culture
  • Describe the impact of artificial intelligence (AI) and rapid change on trust, resilience, and professional fulfillment
  • Identify leadership strategies that support innovation while preserving human connection
  • Review the pathophysiology behind homologous recombination repair-mutated (HRRm) metastatic prostate cancer and the role of poly (ADP-ribose) polymerase (PARP) inhibitors
  • Describe the results of key clinical trials to support the use of PARP inhibitors to treat HRRm metastatic prostate cancer
  • Summarize the indications and roles in therapy of available PARP inhibitors for treating HRRm metastatic prostate cancer
  • Define key counseling points, monitoring parameters, and clinical considerations for PARP inhibitors
  • Describe the role of Pharmacy in NYS' Medical Aid in Dying (MAiD) law
  • Outline the MAiD procedure in NYS
  • Identify updates in NYS laws affecting the practice of pharmacy
  • Describe the prognostic significant & treatment implications of KMT2Ar & NPM1m in AML
  • Discuss key clinical pearls to develop monitoring plans to optimize menin inhibitor therapy
  • Summarize the clinical literature of menin inhibitors both for FDA approved agents & agents in pipeline
  • Describe the risk factors, modes of transmission, and infection cycles associated with the different hepatitis viruses
  • Explain the interpretation of hepatitis B serologic panels and their role in determining infection status and informing prevention and treatment strategies.
  • Discuss the therapeutic goals of hepatitis B treatment and the drug- and patient-specific factors that influence therapy selection and monitoring.

Registration

Registration category

Fee

Link to register

Roswell Park employees 

$20

Register here

Roswell Park Pharmacy Residency Alumni

$20

Register here

Fellows, Resident and Students

$10

Register here

Pharmacists, Physicians and other Healthcare Professionals

$50

Register here

Industry representatives

$250

Register here

Accreditation

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as a knowledge-based activity. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity. No partial credit is available. 

ACPE# 0044-9999-26-028-L01-P
5.0 contact hours, 0.5 CEU

Disclosure declaration

Program speakers: 
Joseph Elijah, Bryan Fitzgerald, Chris Jadoch, and Alex Varkey have nothing to disclose. 

Jeffrey Baron has the following relationships to disclose: 
Consultant/Advisor for SOBI Consultant/Advisor for Daiichi Sankyo 

Program planners: Natali Alberti, Jordan Scott, and Umesh Yogarajah have nothing to disclose. 

All relevant financial relationships have been mitigated.

Financial Support 

This program received no external funding.

Contact us

For general questions about the event, including assistance with registration, please contact Natalie Brock at Natalie.Brock@RoswellPark.org or 716-845-2352.

To contact the Office of Continuing Pharmacy Education at University at Buffalo School of Pharmacy and Pharmaceutical Sciences, please reach out at PharmacyCE@Buffalo.edu.